Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 35, 2005 - Issue 3
Submit an article Journal homepage
114
Views
6
CrossRef citations to date
0
Altmetric
Research Article

In vitro metabolism and in vivo pharmacokinetics of quinoline 3-carboxamide derivatives in various species

H Tuvesson Preclinical Development, Active Biotech Research AB, Lund, Sweden; Department of Cell and Molecular Biology, Lund University, SwedenCorrespondence[email protected]
,
I Hallin Preclinical Development, Active Biotech Research AB, Lund, Sweden
,
M Ellman Preclinical Development, Active Biotech Research AB, Lund, Sweden
,
B Sparre Preclinical Development, Active Biotech Research AB, Lund, Sweden
,
P. O Gunnarsson Preclinical Development, Active Biotech Research AB, Lund, Sweden
&
J Seidegård Astra Zeneca R&D Lund, Sweden; Department of Cell and Molecular Biology, Lund University, Sweden
Pages 293-304 | Received 08 Nov 2004, Published online: 22 Sep 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wolfgang Brück & Scott S Zamvil. (2012) Laquinimod, a once-daily oral drug in development for the treatment of relapsing–remitting multiple sclerosis. Expert Review of Clinical Pharmacology 5:3, pages 245-256.
Read now

Articles from other publishers (5)

Stephenie Prokopec, Raimo Pohjanvirta, Selma Mahiout, Lars Pettersson & Paul Boutros. (2019) Transcriptomic Impact of IMA-08401, a Novel AHR Agonist Resembling Laquinimod, on Rat Liver. International Journal of Molecular Sciences 20:6, pages 1370.
Crossref
Douglas R. Jeffery. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 405 409 .
. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 300 582 .
Douglas R Jeffery. (2008) Development of laquinimod for relapsing–remitting multiple sclerosis. Future Neurology 3:6, pages 641-648.
Crossref
Anna Runström, Tomas Leanderson, Lennart Ohlsson & Bengt Axelsson. (2006) Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-β k.o. and wild type mice. Journal of Neuroimmunology 173:1-2, pages 69-78.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.